BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38530012)

  • 21. Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8
    Duan ZL; Zou WW; Chen D; Zhu JY; Wen JS
    Virus Res; 2024 Jul; 345():199376. PubMed ID: 38643856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.
    Fernandez E; Kose N; Edeling MA; Adhikari J; Sapparapu G; Lazarte SM; Nelson CA; Govero J; Gross ML; Fremont DH; Crowe JE; Diamond MS
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
    Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Generation of Japanese Encephalitis Virus-like Particle Vaccine and Preliminary Evaluation of Its Protective Efficiency].
    Zhang Y; Du R; Huang S; Zhang T; Liu J; Zhu B; Wang H; Deng F; Cao S
    Bing Du Xue Bao; 2016 Mar; 32(2):150-5. PubMed ID: 27396157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
    Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J
    Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China.
    Zheng X; Yu X; Wang Y; Turtle L; Cui M; Wang R; Yin C
    Virol J; 2020 Aug; 17(1):126. PubMed ID: 32831096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice.
    Chang YH; Chiao DJ; Hsu YL; Lin CC; Wu HL; Shu PY; Chang SF; Chang JH; Kuo SC
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
    Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
    Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice.
    Wu Y; Zhang F; Ma W; Song J; Huang Q; Zhang H
    Microbiol Immunol; 2004; 48(8):585-90. PubMed ID: 15322338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus.
    Saga R; Fujimoto A; Watanabe N; Matsuda M; Hasegawa M; Watashi K; Aizaki H; Nakamura N; Tajima S; Takasaki T; Konishi E; Kato T; Kohara M; Takeyama H; Wakita T; Suzuki R
    Sci Rep; 2016 Jun; 6():28688. PubMed ID: 27345289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced immune responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope and porcine interleukin-6 proteins in mice.
    Liu H; Wu R; Liu K; Yuan L; Huang X; Wen Y; Ma X; Yan Q; Zhao Q; Wen X; Cao S
    Virus Res; 2016 Aug; 222():34-40. PubMed ID: 27235810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
    Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
    J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
    Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive mapping of a novel NS1 epitope conserved in flaviviruses within the Japanese encephalitis virus serocomplex.
    Hua RH; Liu LK; Huo H; Li YN; Guo LP; Wang XL; Qin CF; Bu ZG
    Virus Res; 2014 Jun; 185():103-9. PubMed ID: 24631788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.